The Only Specialized Global Intellectual Property News Agency
A Member of Talal Abu-Ghazaleh Global

Noven Files Patent Infringement Lawsuit Against Alvogen

08-Nov-2017 | Source : Noven Pharmaceuticals Inc | Visits : 5201
MIAMI, FL AND JERSEY CITY, NJ - Noven Pharmaceuticals Inc. announced in a press release that it has filed a lawsuit in the US District Court of Delaware against Alvogen, Inc. and Alvogen Pine Brook, LLC. (collectively, “Alvogen”) for patent infringement.

Alvogen is seeking approval to market and sell a generic version of Minivelle® (estradiol transdermal system) prior to the expiration of two of Noven’s Orange Book listed patents (US Patent Nos. 9724310 and 9730900). The lawsuit reflects Noven’s commitment to vigorously enforce its intellectual property rights against infringement.
Regarding this filing, Michael Greene, Noven’s General Counsel, stated, “Minivelle® is Noven’s premier commercialized product. We are confident in the strength of our patent position and it is our intent to aggressively protect Minivelle® and our intellectual property. Any launch by Alvogen of a generic version of Minivelle® prior to resolution of the patent litigation should be considered an “at-risk” launch, which could subject Alvogen to significant damages among other remedies.”

Related Articles